Follow on Google News News By Place Country(s) Industry News
Follow on Google News | Urinary Incontinence affects over 83 million Women across Major Markets Says New ReportPiribo, the online destination for Pharma intelligence, has added a new report.
By: Joe Walsh Urinary incontinence affects over 83 million women across the seven major markets. Anticholinergics form the mainstay of drug treatment yet side effects of dry mouth and constipation often cause patients to discontinue their medication. As such, efficacious drugs with new modes of action and fewer side effects will be well received in the market. While competition in the anticholinergic class is fierce, there is an opportunity for companies with large commercial resources to develop the market further due to the high unmet need and the large patient population. As Pfizer turns its focus elsewhere, Astellas will become the leading company in the urinary incontinence market in 2019. Opportunities exist in targeting niche populations as the sales and marketing spend required to market products populations will be lower, allowing specialist companies to define and own a segment of the market with reduced competition. One such example is Allergan with Botox (botulinum toxin A) in development for neurogenic bladder. The report “Pipeline and Commercial Insight: Urinary Incontinence” http://www.piribo.com/ Piribo product ID: DAT09502 About Piribo Piribo http://www.piribo.com/ # # # About Piribo. Piribo http:www.piribo.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books. End
|
|